The apolipoprotein E (APOE) is the prominent genetic risk factor for AD in the elderly population due to its association in regulating inflammation, cholesterol metabolism, lipid transport, synaptic function, neurogenesis, or generation and trafficking of β-amyloid precursor protein (APP) and Aβ [4,7,8,9]. The gene discussed is APP; the disease is Alzheimer disease.